Tubulin polymerization-IN-24
Tubulin polymerization-IN-24 (compound HMBA) is a potent tubulin polymerization inhibitor. Tubulin polymerization-IN-24 inhibits MCF-7 cells proliferation. Tubulin polymerization-IN-24 induces apoptosis and cell cycle arrest at G2/M phase. Tubulin polymerization-IN-24 increase the GTP hydrolysis rate and inhibits microtubule assembly.
For research use only. We do not sell to patients.
- CAS No.: 564468-51-5
- Formula: C22H16O3
- Molecular Weight:328.36
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| K562 | EC50 |
0.206 μM
Compound: 9h
|
Effective concentration required to arrest propidium iodide stained K562 cells in G2/M phase
Effective concentration required to arrest propidium iodide stained K562 cells in G2/M phase
|
[PMID: 12852768] |
| K562 | IC50 |
0.02 μM
Compound: 8
|
Antiproliferative activity against human K562 cells after 48 hrs by hemocytometer
Antiproliferative activity against human K562 cells after 48 hrs by hemocytometer
|
[PMID: 21705223] |
| K562 | IC50 |
0.02 μM
Compound: 9h
|
In vitro inhibitory concentration against human chronic myelogenous leukemia K562 cell growth
In vitro inhibitory concentration against human chronic myelogenous leukemia K562 cell growth
|
[PMID: 12852768] |
| KB | EC50 |
0.2 μM
Compound: 10
|
Cell cycle arrest in KB/HeLa cells assessed as accumulation at G2/M phase after 24 hrs by flow cytometric analysis
Cell cycle arrest in KB/HeLa cells assessed as accumulation at G2/M phase after 24 hrs by flow cytometric analysis
|
[PMID: 17973361] |
| KB | IC50 |
0.09 μM
Compound: 9h
|
Cytotoxic activity against cellular metabolic activity of Cervix KB/HeLa tumor cell line using XTT proliferation assay after incubation with the compound for 48 h
Cytotoxic activity against cellular metabolic activity of Cervix KB/HeLa tumor cell line using XTT proliferation assay after incubation with the compound for 48 h
|
[PMID: 12852768] |
| L1210 | IC50 |
0.13 μM
Compound: 9h
|
Antiproliferative activity against L1210 phenotype L1210 VCR tumor cell line
Antiproliferative activity against L1210 phenotype L1210 VCR tumor cell line
|
[PMID: 12852768] |
| L1210 | IC50 |
0.14 μM
Compound: 9h
|
Antiproliferative activity against L1210 tumor cell line
Antiproliferative activity against L1210 tumor cell line
|
[PMID: 12852768] |
| LT12 tumor cell line | IC50 |
0.19 μM
Compound: 9h
|
Antiproliferative activity against LT12 phenotype LT12 MDR tumor cell line
Antiproliferative activity against LT12 phenotype LT12 MDR tumor cell line
|
[PMID: 12852768] |
| LT12 tumor cell line | IC50 |
0.32 μM
Compound: 9h
|
Antiproliferative activity against LT12 tumor cell line
Antiproliferative activity against LT12 tumor cell line
|
[PMID: 12852768] |
| Lung LXF 629L tumor cell line | IC50 |
<0.01 μM
Compound: 9h
|
Tested for induction of cellular death in Human lung LXF 629L tumor cell line in Propidium Iodide Monolayer Assay
Tested for induction of cellular death in Human lung LXF 629L tumor cell line in Propidium Iodide Monolayer Assay
|
[PMID: 12852768] |
| LXFL 529 | IC50 |
0.52 μM
Compound: 9h
|
Tested for induction of cellular death in Human lung LXF 529L tumor cell line in Propidium Iodide Monolayer Assay
Tested for induction of cellular death in Human lung LXF 529L tumor cell line in Propidium Iodide Monolayer Assay
|
[PMID: 12852768] |
| MAXF401 cell line | IC50 |
<0.01 μM
Compound: 9h
|
Tested for induction of cellular death in Human breast 401NL tumor cell line in Propidium Iodide Monolayer Assay
Tested for induction of cellular death in Human breast 401NL tumor cell line in Propidium Iodide Monolayer Assay
|
[PMID: 12852768] |
| MCF7 | IC50 |
<0.01 μM
Compound: 9h
|
Tested for induction of cellular death in Human breast MCF-7 tumor cell line in Propidium Iodide Monolayer Assay
Tested for induction of cellular death in Human breast MCF-7 tumor cell line in Propidium Iodide Monolayer Assay
|
[PMID: 12852768] |
| NCI-H460 | IC50 |
<0.01 μM
Compound: 9h
|
Tested for induction of cellular death in Human lung H-460 tumor cell line in Propidium Iodide Monolayer Assay
Tested for induction of cellular death in Human lung H-460 tumor cell line in Propidium Iodide Monolayer Assay
|
[PMID: 12852768] |
| NCI-H460 | IC50 |
0.07 μM
Compound: 9h
|
Cytotoxic activity against cellular metabolic activity of Lung NCI-H460 tumor cell line using XTT proliferation assay after incubation with the compound for 48 h
Cytotoxic activity against cellular metabolic activity of Lung NCI-H460 tumor cell line using XTT proliferation assay after incubation with the compound for 48 h
|
[PMID: 12852768] |
| P388/ADR | IC50 |
0.16 μM
Compound: 9h
|
Antiproliferative activity against P388 tumor cell line
Antiproliferative activity against P388 tumor cell line
|
[PMID: 12852768] |
| P388/ADR | IC50 |
0.26 μM
Compound: 9h
|
Antiproliferative activity against P388 phenotype P388 ADR tumor cell line
Antiproliferative activity against P388 phenotype P388 ADR tumor cell line
|
[PMID: 12852768] |
| RKO | IC50 |
>9 μM
Compound: 9h
|
Cytotoxic activity against human colon adenocarcinoma RKO cells with ectopic inducible expression of cyclin-dependent kinase inhibitor p27kip1
Cytotoxic activity against human colon adenocarcinoma RKO cells with ectopic inducible expression of cyclin-dependent kinase inhibitor p27kip1
|
[PMID: 12852768] |
| RKO | IC50 |
0.06 μM
Compound: 9h
|
Cytotoxic activity against human colon adenocarcinoma RKO cells without ectopic inducible expression of cyclin-dependent kinase inhibitor p27kip1
Cytotoxic activity against human colon adenocarcinoma RKO cells without ectopic inducible expression of cyclin-dependent kinase inhibitor p27kip1
|
[PMID: 12852768] |
| RXF 944 | IC50 |
<0.01 μM
Compound: 9h
|
Tested for induction of cellular death in Human renal RXF 944L tumor cell line in Propidium Iodide Monolayer Assay
Tested for induction of cellular death in Human renal RXF 944L tumor cell line in Propidium Iodide Monolayer Assay
|
[PMID: 12852768] |
| SF-268 | IC50 |
0.03 μM
Compound: 9h
|
Tested for induction of cellular death in Human ZNS SF-268 tumor cell line in Propidium Iodide Monolayer Assay
Tested for induction of cellular death in Human ZNS SF-268 tumor cell line in Propidium Iodide Monolayer Assay
|
[PMID: 12852768] |
| SF-268 | IC50 |
0.05 μM
Compound: 9h
|
Cytotoxic activity against cellular metabolic activity of Glioma SF-268 tumor cell line using XTT proliferation assay after incubation with the compound for 48 h
Cytotoxic activity against cellular metabolic activity of Glioma SF-268 tumor cell line using XTT proliferation assay after incubation with the compound for 48 h
|
[PMID: 12852768] |
| SK-OV-3 | IC50 |
0.05 μM
Compound: 9h
|
Cytotoxic activity against cellular metabolic activity of Ovary SKOV3 tumor cell line using XTT proliferation assay after incubation with the compound for 48 h
Cytotoxic activity against cellular metabolic activity of Ovary SKOV3 tumor cell line using XTT proliferation assay after incubation with the compound for 48 h
|
[PMID: 12852768] |
Tubulin polymerization-IN-24 (compound HMBA) inhibits the assembly of purified tubulin (MAPs-free) in a concentration dependent manner[1].
Tubulin polymerization-IN-24 (0-100 nM) inhibits MCF-7 proliferation in a concentration dependent fashion with an IC50 value of 47 nM[1].
Tubulin polymerization-IN-24 competitively inhibits colchicine binding to tubulin with a Ki value of 3.6 μM[1].
Tubulin polymerization-IN-24 inhibits the progression of MCF-7 cells in mitosis and induces apoptotic cell death involving p53 pathway[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 564468-51-5
-
Molecular Weight 328.36
-
Formula C22H16O3
-
SMILES
O=C1C2=C(C=CC=C2)/C(C3=CC=CC=C13)=C\C4=CC=C(OC)C(O)=C4
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)